01.002 RWE TNT May 2022 A

Machine Learning used in real-world analysis of COVID-19 pharmacotherapy

  • Real-world data generated from clinical practice can be used to analyse the real-world evidence (RWE) of COVID-19 pharmacotherapy and validate the results of randomised clinical trials (RCTs)
  • 5244 and 1312 COVID-19 hospital admissions – dated between January 2020 and January 2021 from 10 health departments, were used respectively for training and validation of separate treatment-effect models for remdesivir, corticosteroids, tocilizumab, lopinavir-ritonavir, azithromycin and chloroquine/hydroxychloroquine
  • Machine Learning (ML) methods are suitable tools toward RWE analysis of COVID-19 pharmacotherapies. Results obtained reproduce published results on RWE and validate the results from RCTs

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at